CARD9 pathway as a potential therapeutic target in allergic airway disease March 13, 2019 No Comments
Phase III studies of triple combination of VX-445, tezacaftor and ivacaftor meet primary endpoint March 7, 2019 No Comments
LGM-2605 protects from ozone-induced airway inflammation and hyperreactivity in rhesus macaques March 6, 2019 No Comments
Verona reports part one data from phase II trial of DPI formulation of ensifentrine in COPD March 4, 2019 No Comments
Bayer presents novel adenosine A2B receptor antagonist with potential for lung fibrosis Feb. 28, 2019 No Comments
Detailed results from phase III trials of Dupixent in chronic rhinosinusitis with nasal polyps Feb. 26, 2019 No Comments
RSS